A Non-Interventional, Registry Study for Chinese Gastric Cancer Patients With HER2 Status: Clinical and Pathological Characteristics, Treatment Patterns and Clinical Outcomes (EVIDENCE)
Phase of Trial: Phase IV
Latest Information Update: 21 Mar 2018
At a glance
- Drugs Trastuzumab (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms EVIDENCE
- Sponsors Roche
- 16 Mar 2018 Status changed from active, no longer recruiting to completed.
- 29 Jan 2018 Planned End Date changed from 21 Nov 2017 to 28 Feb 2018.
- 29 Jan 2018 Planned primary completion date changed from 21 Nov 2017 to 28 Feb 2018.